The concentrations of morphine and 6-acetylmorphine (6-AM) in urine, cerebrospinal fluid (CSF), and vitreous humor (VH) and the morphine concentrations in blood were determined by gas chromatography-mass spectrometry for 29 fatalities after abuse of heroin either alone or in combination with alcohol and other drugs. 6-AM was found above a quantitation limit of I ng/ml, in urine in 89% of the cases, in CSF in 68% of the cases, and in VH in 75% of the cases. The 6-AM concentrations in CSF (mean, 10 ng/mL) and VH (mean, 17 ng/mL) were in general much smaller than in urine (mean, 170 ng/mL); therefore, the different pharmacokinetic behavior of the fluids is discussed. There is no uniformity between the three fluids with respect to the presence or absence of 6-AM. Therefore, CSF or VH may be used as complementary or alternative materials to urine in order to prove heroin uptake in opiate fatalities.
Introduction
The detection of the primary heroin metabolite 6-acetylmorphine (6-AM) is generally regarded as an indicator of administration of heroin rather than morphine (1--6) . Because of the high esterase activity of blood and most tissues, which continues after death, 6-AM can be found in these samples only within a short time period after use (5, 7) . Therefore, for this purpose, urine is the preferred analysis material, in which the enzymatic hydrolysis is limited. The described window of time for 6-AM detection in urine is between 2 and 8 h after injection of heroin (6) , and concentrations between 3 ng/mL and 10 lJg/mL were measured (1) (2) (3) (4) (5) (6) .
Substantial concentrations of 6-AM have also been found in cerebrospinal fluid (CSF), brain and spleen (6) , vitreous humor (VII) (8) , saliva (9) , and hair (I0). Lin et al. (8) reported 6-AM concentrations in VII between 10 and 125 nglmL for 41 out of 223 fatalities after heroin overdose. Goldberger et al. (5) found CSF concentrations of 58.0 and 38.5 nglmL in two postmortem cases. On the other hand, Bogusz et al. (11) , who determined 6-MA along with morphine and its glucuronides in 2i heroin overdose cases by liquid chromatography-mass spectrometry, found only 0-3 nglmL in CSF in I0 cases and traces-7 nglmL in VH in 3 cases.
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In this paper we describe the results of the determination of morphine and 6-AM in urine, CSF, and VII for 29 drug fatalities. These determinations were carried out in the framework of a broader investigation about the suitability of CSF and VH as materials for toxicological analysis (12) .
Materials and Methods

Drug fatalities and blood, urine, CSF, and VH specimens
The samples were collected during the autopsies for 29 drugrelated fatalities. Used syringes and fresh injection marks were found in 27 of the cases, proving that the administration of the drugs had occured by injection. In Case 27, only a pipe with drug residues was found, and there were no injection marks, indicating that the drug had been smoked. In Case 15, the manner of administration could not be established. In addition to the detection of 6-AM, the uptake of heroin was also proved by the analytical investigation of the syringes and, as far as available, of the drug spoons or powders found with the deceased. The time between death and autopsy was 1-8 days, during which time the corpses were refrigerated. Only subjects without noticeable putrefaction were selected for this investigation.
CSF was obtained intracranially from the subdural cavity after craniotomy. VII was collected by ocular puncture. Care was taken to avoid contamination of the samples by blood. As a rule, the liquids were homogeneous and clear. If there was a small amount of undissolved material, it was removed by centrifugation. The samples were stored without any inhibitor at 0-4~ and analyzed within 3-7 days after autopsy.
In order to examine the stability of 6-AM in these body fluids, I 1Jg was dissolved in each 2 mL of CSF and 2 mL of VH obtained from other cases. Aliquots (0.5 mL) of these solutions were analyzed as described immediately and after i and 7 days storage at 0-4~ No remarkable decomposition of 6-AM within this time was observed.
Reagents and reference compounds
Morphine, 6-AM, and morphine-d3 were purchased from Radian Corp. Trifluoroacetic anhydride (TFAA), organic solvents (analytical grade), and Extrelut | extraction columns (3 mL) were obtained from Merck/Darmstadt.
Sample preparation
One milliliter of the sample, 1 mL of 1M carbonate buffer (pH 8.9), and 50 IJL of the internal standard solution (10 pg/mL morphine-d3 in isopropanol) were vortex mixed and adsorbed onto a 3-mL Extrelut column. After 15 rain, the analytes were eluted with 15 mL of ethyl acetate/diethyl ether (1:1, v/v), the e luent was removed with a rotary evaporator, and the residue was defivatized with 50 IJL TFAA for 40 min at 80~ After evaporation of TFAA with a nitrogen stream, the residue was dissolved in 50 IJL of dichloromethane for GC-MS analysis.
GC-MS measurements
The Hewlett-Packard GC-MS consisted of an HP 5890 series II GC, an HP 5971 mass selective detector and an HP 7673 autosampler. An HP-5 capillary column (25 m x 0.25-ram i.d., 0.25-1Jm film thickness, 95% dimethylsiloxane, 5% diphenylsiloxane) was used for the chromatographic separation with a carrier gas flow rate of I mL/min and the following temperature program: hold at 120~ for 2 rain, then ramp to 280~ at 20~ then hold at 280~ for 10 min. The temperatures of the injector, GC-MS interface, and ion source were 270, 310, and 181~ respectively. For the selected ion monitoring (SIM) of the TFAA-derivatives, the following mass-to-charge ratio values were selected: morphine, 364 and 477 (ion ratio 4:1); morphine-d3, 367 and 480; 6-acetylmorphine, 364 and 423 (ion ratio 1.9:1); and codeine, 282 and 395 (ion ratio 1.7:1). The dwell time was 50 ms.
The precision of the method was determined to 10% using samples of CSF and VH from nonpoisoned fatalities spiked with 6-AM (50 ng/mL, n = 5). In the same way, the limit of detection (0.3 ng/mL) and the limit of quantitation (1 ng/mL) were estimated from the signal-to-noise ratio of about 10:1 after spiking of CSF and VH samples with 6-AM (1 ng/mL, n = 5). The calibration curves with respect to the internal standard morphine-d3 of 6-AM and morphine were linear between 1 ng/mL and 10 IJg/mL (correlation coefficient of the bilogarithmic plot: r = 0.994 for 6-AM and 0.996 for morphine). Examples of SIM-chromatograms for urine, CSF, and VH are shown in Figure 1 . 
Other toxicological investigations
In all cases a general analytical investigation for alcohol and other volatile substances, further illegal drugs, medical drugs, pesticides, and other poisons was carried out using headspace GC of blood and urine; (GC 8600 with automatic headspace injector HS101, Perkin Elmer), enzyme immunoassay EMIT of urine for amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone, and opiates (Syva-Behring GmbH); high-performance liquid chromatography (HPLC) with photodiode-array detection; and library search after extraction of blood and stomach content at pH 2.3 and 9.0, respectively (HPLC pump LC-6A, autoinjector SIL-9A, photodiode-array detector SPD-M6A, Shimadzu. For chromatographic conditions and spectra library of toxic compounds, compare with reference 13). Positive HPLC results were confirmed by GG--MS or thin-layer chromatography.
Results and Discussion
The results obtained in the toxicological investigations of the 29 cases are shown in Table I . In all cases an intoxication was established as the cause of death. However, only in 12 cases heroin was the only effective poison, whereas an intoxication by heroin combined with alcohol, cocaine, tricyclic antidepressants, benzodiazepines, or local anesthetics (lidocaine or tetracaine, which were used as substitutes in cocaine formulations) was found in 16 cases. In Case 19, death was caused solely by an injection of tetracaine several hours after a preceding injection of a drug mixture containing heroin.
In the GC-MS analysis for opiates, blood was investigated in all cases, whereas urine, CSF, and VII were available only in 27, 22, and 28 cases, respectively. The morphine concentrations in blood (0.03-5.8 ]Jg/mL) and in urine (0.025-27 IJg/mL) are in a range generally found in fatalities after heroin injection (14) . The broad variation of the values can be explained by differences in opiatetolerance and in survival time after the injection. With the exception of the Cases 20 and 27, the morphine concentrations in CSF and VII were lower than in blood (between 2 (12) and can be explained by an incomplete distribution of the drug in cases with a short survival time and by the plasma-protein binding of morphine (about 35% [15] ) leading to a smaller equilibrium concentration in CSF and VH. Because CSF and VH contain almost no protein, the equilibrium concentration in these fluids under vital conditions is almost identical to that not bound to protein in blood (about 65%). 6-AM was found in urine in 24 of 27 samples with concentrations between 2 and 1600 ng/mL. For CSF, a positive 6-AM result (1-30 ng/mL) was obtained in 15 of 22 cases, and for VH, 21 of 28 cases were above the quantitation limit (1-80 ng/mL). On average, the 6-AM concentrations in CSF and VH were about one order of magnitude smaller than in urine. However, there is no uniform behavior with respect to the 6-AM concentration between urine and CSF and VII. For example, in Cases 15, 26, 27, or 29, which had comparatively high urine concentrations, the values in CSF and VII were rather small or below the detection limit. However, in Cases 1-4, 8, or 17 , the urine concentrations were relatively small, and there were higher concentrations in CSF and VH.
A possible explanation for this could be the different pharmacokinetic behavior of the three fluids. Urine is irreversibly formed in the kidney and collected in the bladder. Because of the short half-life of 6-AM in blood (tin = 40 rain), the urine concentration depends on the activity of the kidneys within the first hours after the injection and on the time of the last bladder emptying before death. If the death occurs immediately after the injection, very small 6-AM concentrations are expected in urine. On the other hand, the concentrating effect of the kidneys produces a relatively high 6-AM content in urine, especially for longer survival times. Because of the lack of esterases, 6-AM is rather stable in this fluid.
CSF and VII have a similar pharmacokinetic behavior (16--18). The blood-brain barrier and the blood-ocular barrier restrict the entrance of drugs to lipophilic or very small hydrophilic substances. The distribution equilibrium between blood and both of these almost protein-free fluids in vivo is determined by the plasma-protein binding. Both fluids are involved in a continuous process of generation and elimination. The turnover time of CSF between its formation at the plexus chorioidei and its elimination at the arachnoidal granulations is described between 5 and 7 h (19) . For VII, a free exchange of water and of drugs is possible with the aqueous humor of the posterior chamber, which has a turnover time of about 100 rain (20) . After direct injection into CSF or VH, the elimination of lipophilic drugs occurs preferentially and relatively quickly by diffusion through the membranes, whereas hydrophilic drugs are more slowly eliminated together with the fluid streams (21, 22) .
Therefore, lipophilic compounds such as 6-AM should penetrate into CSF and VII within a relatively short time after the injection. During the survival time of the subject, the concentration in these fluids should follow the blood concentration with a certain delay at a concentration ratio Ccsr/Cbiood or Cvn/Cblood determined by the plasma-protein binding. For this reason, for substances unstable in blood, the time window of detection could be shorter than in urine. After death, the hydrolysis of 6-AM in blood continues, whereas in CSF and VII it is more or less stable.
It is seen from Table I that the 6-AM concentrations in CSF are somewhat smaller than in VH in most cases. Possibly a slow hydrolysis of 6-AM by esterases occurs during the contact with brain tissue. Moreover, a contamination during sampling by traces of blood, which contains esterases, is more probable for CSF than for VH, although samples contaminated by visible amounts of blood were excluded from these investigations. In samples of CSF and VH, to which 6-AM was added in order to examine its stability, remarkable decomposition of 6-AM during storage for 7 days between 0 and 4~ was found neither in CSF nor in VII.
As far as possible, the length of survival time after drug injection was compared with the 6-AM concentrations. In 12 cases, a rough estimate of the survival time after injection was possible from the police reports. In six cases, the subjects were observed during the injection or were found still alive immediately after the injection and died within 30 min. In another five cases, a short survival time was assumed from the circumstances of the discovery of the body; for example, the syringe was still sticking in the vein. A longer survival time could be assumed in Case 15, where the deceased was heard snoring in his bed several hours before he died, and in Case 19, where heroin was obviously injected several hours before a lethal tetracaine overdose. The 6-AM concentrations in urine, CSF, and VH of the short-survivaltime cases vary widely, and there is no significant difference compared with the two cases with a longer survival time.
In conclusion, it is shown by these investigations that the analysis of CSF and VII for 6-AM may deliver positive results in cases in which the urine test is negative. Therefore, both fluids are useful complementary or alternative materials in order to discriminate between heroin and morphine administration. Beyond that, it seems difficult to obtain further evidence (e.g., about the survival time) from the 6-AM concentrations.
